tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amphastar Pharmaceuticals’ Mixed Earnings Call Insights
PremiumCompany AnnouncementsAmphastar Pharmaceuticals’ Mixed Earnings Call Insights
2M ago
Amphastar price target lowered to $35 from $40 at Wells Fargo
Premium
The Fly
Amphastar price target lowered to $35 from $40 at Wells Fargo
2M ago
Cautious Hold Rating for Amphastar Pharmaceuticals Amid Competitive Pressures and Revenue Challenges
Premium
Ratings
Cautious Hold Rating for Amphastar Pharmaceuticals Amid Competitive Pressures and Revenue Challenges
2M ago
Amphastar price target lowered to $32 from $36 at Piper Sandler
PremiumThe FlyAmphastar price target lowered to $32 from $36 at Piper Sandler
4M ago
Amphastar’s Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Amphastar’s Earnings Call: Growth Amid Challenges
5M ago
Amphastar price target lowered to $36 from $44 at BofA
Premium
The Fly
Amphastar price target lowered to $36 from $44 at BofA
5M ago
Amphastar downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyAmphastar downgraded to Neutral from Overweight at Piper Sandler
6M ago
Correction: Amphastar did not report Q4 earnings this morning
Premium
The Fly
Correction: Amphastar did not report Q4 earnings this morning
6M ago
Amphastar reports Q4 adjusted EPS 55c, consensus 50c
Premium
The Fly
Amphastar reports Q4 adjusted EPS 55c, consensus 50c
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100